Lineage, Inc. Common Stock (LINE)vsPennyMac Mortgage Investment Trust (PMT)
LINE
Lineage, Inc. Common Stock
$42.36
+4.23%
REAL ESTATE · Cap: $10.62B
PMT
PennyMac Mortgage Investment Trust
$9.65
+3.32%
REAL ESTATE · Cap: $822.32M
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 790% more annual revenue ($5.36B vs $602.22M). PMT leads profitability with a 27.6% profit margin vs -2.7%. PMT earns a higher WallStSmart Score of 66/100 (B-).
LINE
Hold36
out of 100
Grade: F
PMT
Strong Buy66
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for LINE.
Margin of Safety
+74.8%
Fair Value
$49.06
Current Price
$9.65
$39.41 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Attractively priced relative to earnings
Reasonable price relative to book value
Keeps 28 of every $100 in revenue as profit
Growing faster than its price suggests
Strong operational efficiency at 20.8%
Areas to Watch
0.4% revenue growth
0.0% earnings growth
Operating margin of 3.3%
Elevated debt levels
Smaller company, higher risk/reward
ROE of 7.7% — below average capital efficiency
Weak financial health signals
Revenue declined 50.5%
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : PMT
The strongest argument for PMT centers on P/E Ratio, Price/Book, Profit Margin. Profitability is solid with margins at 27.6% and operating margin at 20.8%. PEG of 0.76 suggests the stock is reasonably priced for its growth.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : PMT
The primary concerns for PMT are Market Cap, Return on Equity, Piotroski F-Score. Debt-to-equity of 10.87 is elevated, increasing financial risk.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while PMT is a declining play — different risk/reward profiles.
PMT carries more volatility with a beta of 1.12 — expect wider price swings.
LINE is growing revenue faster at 0.4% — sustainability is the question.
LINE generates stronger free cash flow (-55M), providing more financial flexibility.
Bottom Line
PMT scores higher overall (66/100 vs 36/100), backed by strong 27.6% margins. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.
Visit Website →PennyMac Mortgage Investment Trust
REAL ESTATE · REIT - MORTGAGE · USA
PennyMac Mortgage Investment Trust, a specialty finance company, invests primarily in mortgage-related assets in the United States. The company is headquartered in Westlake Village, California.
Visit Website →Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?